Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
6.975 USD | +4.10% | -1.69% | -37.61% |
May. 15 | HC Wainwright Adjusts Fennec Pharmaceuticals Price Target to $15 From $18, Maintains Buy Rating | MT |
May. 14 | Transcript : Fennec Pharmaceuticals Inc., Q1 2024 Earnings Call, May 14, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-37.61% | 183M | |
+9.92% | 118B | |
+10.27% | 106B | |
-11.33% | 23.4B | |
-1.69% | 22.1B | |
-10.23% | 18.34B | |
-41.92% | 16.59B | |
-15.68% | 15.97B | |
+6.88% | 14.03B | |
+18.06% | 11.67B |
- Stock Market
- Equities
- FENC Stock
- News Fennec Pharmaceuticals Inc.
- Fennec Pharmaceuticals Insider Sold Shares Worth $433,996, According to a Recent SEC Filing